Monocyte implication in renal allograft dysfunction

Clinical and Experimental Immunology

Volumn 175, Issue 2, 2014, Pages 323-331

  Guillen Gomez E ^a   Guirado, L ^a   Belmonte, X ^a   Maderuelo, A ^a   Santin S ^a   Juarez, C ^b   Ars, E ^a   Facundo, C ^a   Ballarin J A ^a   Vidal, S ^b   Diaz Encarnacion M M ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Allograft dysfunction; Inflammation; Monocytes; Renal transplantation

Indexed keywords

BASILIXIMAB; CD163 ANTIGEN; CREATININE; HLA DR ANTIGEN; INTERLEUKIN 10; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ANTIGEN PRESENTING CELL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL GRAFT DYSFUNCTION;

ALLOGRAFT DYSFUNCTION; INFLAMMATION; MONOCYTES; RENAL TRANSPLANTATION;

ALLOGRAFTS; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CREATININE; FEMALE; FIBROSIS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-10; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; MYCOPHENOLIC ACID; PHENOTYPE; PREDNISONE; PRIMARY GRAFT DYSFUNCTION; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; RECEPTORS, IGG; SPAIN; TACROLIMUS;

EID: 84891589454     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12228     Document Type: Article

References (48)

1. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349:2326-2333.
2. Cosio FG, Grande JP, Larson TS etal. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005; 5:1130-1136.
3. Kaplan B, Meier-Kriesche HU. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant 2002; 2:970-974.
4. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75:1291-1295.
5. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 1997; 12:43-50.
6. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110:341-350.
7. Van Goor H, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR. Macrophages and renal disease. Lab Invest 1994; 71:456-464.
8. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 1991; 40:1020-1031.
9. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 1992; 141:1381-1396.
10. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994; 5:201-209.
11. Diamond JR. Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kidney Dis 1995; 26:133-140.
12. Mannon RB, Kopp JB, Ruiz P etal. Chronic rejection of mouse kidney allografts. Kidney Int 1999; 55:1935-1944.
13. Magil AB. Monocytes/macrophages in renal allograft rejection. Transplant Rev (Orlando) 2009; 23:199-208.
14. Pilmore HL, Painter DM, Bishop GA, McCaughan GW, Eris JM. Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation 2000; 69:2658-2662.
15. Park WD, Griffin MD, Cornell LD, Cosio FG, Stegall MD. Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol 2010; 21:1987-1997.
16. Hueso M, Navarro E, Moreso F etal. Intragraft expression of the IL-10 gene is up-regulated in renal protocol biopsies with early interstitial fibrosis, tubular atrophy, and subclinical rejection. Am J Pathol 2010; 176:1696-1704.
17. Lange-Sperandio B, Trautmann A, Eickelberg O etal. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol 2007; 171:861-871.
18. Mannon RB. Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders? Curr Opin Organ Transplant 2012; 17:20-25.
19. Lee S, Huen S, Nishio H etal. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22:317-326.
20. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19:71-82.
21. Van den Heuvel MM, Tensen CP, van As JH etal. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999; 66:858-866.
22. Fabriek BO, Dijkstra CD, Van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology 2005; 210:153-160.
23. Moestrup SK, Moller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004; 36:347-354.
24. Hogger P, Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 2001; 288:841-843.
25. Kim KS, Denton MD, Chandraker A etal. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. Am J Pathol 2001; 158:977-986.
26. McAdam AJ, Schweitzer AN, Sharpe AH. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev 1998; 165:231-247.
27. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007; 37:14-16.
28. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13:453-461.
29. Quimby KR, Greenidge A, Harris A, Landis RC. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass. Cytometry B Clin Cytom 2010; 78:357-360.
30. Polfliet MM, Fabriek BO, Daniels WP, Dijkstra CD, Van den Berg TK. The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production. Immunobiology 2006; 211:419-425.
31. Goldstein JI, Goldstein KA, Wardwell K etal. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. Atherosclerosis 2003; 170:325-332.
32. Philippidis P, Athanasiou T, Nadra I etal. Anti-inflammatory haemoglobin scavenging monocytes are induced following coronary artery bypass surgery. Eur J Cardiothorac Surg 2010; 37:1360-1366.
33. Yonemoto S, Machiguchi T, Nomura K, Minakata T, Nanno M, Yoshida H. Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitus. Clin Exp Nephrol 2006; 10:186-192.
34. Sulahian TH, Hogger P, Wahner AE etal. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000; 12:1312-1321.
35. Fingerle-Rowson G, Auers J, Kreuzer E etal. Down-regulation of surface monocyte lipopolysaccharide-receptor CD14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operation. J Thorac Cardiovasc Surg 1998; 115:1172-1178.
36. Nockher WA, Scherberich JE. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro. J Immunol 1997; 158:1345-1352.
37. Piemonti L, Monti P, Allavena P etal. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 1999; 162:6473-6481.
38. Vanderheyde N, Verhasselt V, Goldman M, Willems F. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999; 67:1342-1347.
39. Girndt M, Sester U, Kaul H, Hunger F, Kohler H. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. Transplantation 1998; 66:370-375.
40. Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR, Van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000; 30:1807-1812.
41. Kawasaki T, Ogata M, Kawasaki C, Tomihisa T, Okamoto K, Shigematsu A. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 2001; 92:1322-1326.
42. Klava A, Windsor A, Boylston AW, Reynolds JV, Ramsden CW, Guillou PJ. Monocyte activation after open and laparoscopic surgery. Br J Surg 1997; 84:1152-1156.
43. Mokart D, Textoris J, Chow-Chine L etal. HLA-DR and B7-2 (CD86) monocyte expressions after major cancer surgery: profile in sepsis. Minerva Anestesiol 2011; 77:522-527.
44. Veenhof AA, Vlug MS, van der Pas MH etal. Surgical stress response and postoperative immune function after laparoscopy or open surgery with fast track or standard perioperative care: a randomized trial. Ann Surg 2012; 255:216-221.
45. Chai JG, Bartok I, Chandler P etal. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999; 29:686-692.
46. Lenschow DJ, Zeng Y, Hathcock KS etal. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 1995; 60:1171-1178.
47. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62:311-318.
48. First MR. Renal function as a predictor of long-term graft survival in renal transplant patients. Nephrol Dial Transplant 2003; 18 (Suppl. 1):i3-i6.